Table 2.
miRNAs for Therapy.
| Type of Nanocarrier | Target miRNAs | Target | References |
|---|---|---|---|
| Nanoparticles | MiR-17, miR-21 | Prostate cancer cell | [97]—Binzel D et al. (2016) |
| miR-21 | Pancreatic cancer cell | [98]—Li Y et al. (2017) | |
| MiR-10b-a | Tumour | [99]—Yoo B et al. (2017) | |
| miR-145 | Cancer | [100]—Tekie F et al. (2018) | |
| miR-21 | Ovarian cancer cells | [101]—Vandghanooni S et al. (2018) | |
| miR-148a, miR-296-5p | Glioblastoma cells | [102]—Lopez-Bertoni H et al. (2018) | |
| miR-34a | Breast cancer cells | [103]—Panebianco F et al. (2019) | |
| miR-100, miR-21 | Glioblastoma | [104]—Sukumar U et al. (2019) | |
| miR-29b | Leukaemia | [105]—Chiang C et al. (2019) | |
| miR-29b | Lung cancer | [106]—Perepelyuk M et al. (2018) | |
| miR-21 | Breast cancer | [107]—Qian R et al. (2018) | |
| miR-21, miR-221 | Breast cancer | [108]—Chen W et al. (2019) | |
| miR-21, miR-155 | Cancer | [109]—Zhang P et al. (2021) | |
| MiR-21 | Triple-negative breast cancer | [110]—Yin H et al. (2019) | |
| miR-34a, miR-10b | Triple-negative breast cancer | [111]—Ahir M et al. (2020) | |
| miR-376b | HER2-positive breast cancer | [112]—Unal O et al. (2020) | |
| miR-34a, miR-16 | Non-small-cell lung cells | [113]—Upadhyay P et al. (2019) | |
| miRNA-145 | Colon cancer cells | [114]—Shi H et al. (2019) | |
| miR-let-7c-5p | HeLa cells | [115]—Shao L et al. (2020) | |
| miRNA-124, miRNA-21 | Glioblastoma cells | [116]—Liu Y et al. (2021) | |
| miR-let-7b | Lung cancer cells | [117]—Maghsoudnia N et al. (2020) | |
| miR-122 | Tumour cells | [118]—Wang H et al. (2021) | |
| miR-181 | Oesophageal cancer | [119]—Zhou X et al. (2021) | |
| Nanoplatforms/nanosystems | miR-21 | Breast cancer cells | [120]—Kim H et al. (2017) |
| miR-101 | MCF7, MDA- MB-231 | [121]—Assali A et al. (2018) | |
| MiR-101 | Breast cancer cells | [122]—Assali A et al. (2018) | |
| Breast cancer cells | [123]—Luo Y et al. (2021) | ||
| Extracellular vesicles | miR-21 | SKBR3 cells | [76]—JC Bose R et al. (2018) |
| Exosomes | miR-142-3p, miR-150 | Breast cancer cells | [89]—Nseri Z et al. (2018) |
| miR-34a | Breast cancer cells | [90]—Vakhshiteh F et al. (2021) | |
| miR-130 | Breast cancer cells | [91]—Moradi-Chaleshtori M et al. (2021) | |
| Micelles | miR-21 | Cancer cells | [93]—Yin H et al. (2018) |
| miR-210 | Breast cancer cells | [95]—Li Y et al. (2017) | |
| Niosomes | miR-15a, miR-16-1 | Prostate cancer cells | [96]—Ghaffari M et al. (2021) |